CCFM
STML

Clear Creek Financial Management’s Stemline Therapeutics, Inc. STML Stock Holding History

Clear Creek Financial Management’s Portfolio STML Stock Details STML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-15,000
Closed -$79K – 276
2020
Q1 		$79K Buy
+15,000
New +$97.3K 0.03% 163

Clear Creek Financial Management's STML Position: Q2 2020 in Review

Clear Creek Financial Management sold out of Stemline Therapeutics, Inc. (STML) in Q2 2020, closing a stake of 15,000 shares — an estimated $79K sold.

Clear Creek Financial Management first reported a position in STML in Q1 2020 and held it in 1 quarter. The position peaked at $79K in Q1 2020. 0 funds tracked by Wall St. Rank hold STML as of Q2 2020.

  • Clear Creek Financial Management reported no remaining Stemline Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
  • Clear Creek Financial Management sold 15,000 Stemline Therapeutics, Inc. shares in Q2 2020, an estimated $79K.
  • Clear Creek Financial Management first reported a position in Stemline Therapeutics, Inc. in Q1 2020 and held it in 1 quarter.
  • Clear Creek Financial Management's Stemline Therapeutics, Inc. position peaked at $79K in Q1 2020.
  • 0 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q2 2020.

Based on Clear Creek Financial Management's 13F filing for Q2 2020, filed 16 Jul 2020.